Načítá se...
Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer
The initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and c...
Uloženo v:
| Vydáno v: | Interface Focus |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Royal Society
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6388024/ https://ncbi.nlm.nih.gov/pubmed/30842876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsfs.2018.0077 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|